Measuring Clinically Meaningful Change Following Mental Health Treatment

Susan V. Eisen1,2, Gayatri Ranganathan3, Pradipta Seal1, Avron Spiro4,5
1Center for Health Quality Outcomes and Economic Research (CHQOER), Edith Nourse Rogers Memorial Veterans Hospital, Bedford, USA
2Department of Health Policy and Management, Boston University School of Public Health, Boston, USA
3MetaWorks Inc., Medford, USA
4Department of Epidemiology, Boston University School of Public Health, Boston, USA
5Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Newman FL, Ciarlo JA, Carpenter D. Guidelines for selecting psychological instruments for treatment planning and outcome assessment. In: Maruish M, ed. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment 2nd Edition. Mahwah, NJ: Lawrence Erlbaum; 1999:153–170.

Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. Journal of Chronic Disease. 1987;40:171–178.

Liang MH. Longitudinal construct validity: Establishment of clinical meaning in patient evaluation instruments. Medical Care. 2000;38(Suppl II):S84–S90.

Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Quality of Life Research. 1993;2:441–449.

Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. Journal of Evaluation in Clinical Practice. 2000;6:39–49.

McHorney CA, Tarlow AR. Individual patient monitoring in clinical practice: are available health status surveys adequate? Quality of Life Research. 1995;4(4):293–307.

Hays RD, Brodsky M, Johnston MF, et al. Evaluating the statistical significance of health-related quality-of-life change in individual patients. Evaluation & the Health Professions. 2005;28:160–171.

Wyrwich KW, Bullinger M, Aaronson N, et al. Estimating clinically significant differences in quality of life outcomes. Quality of Life Research. 2005;14:285–295.

Glossary. Health outcomes methodology. Medical Care. 2000;38(9 Suppl. II,II-7-II-13):2–10).

Atkins DC, Bedics JD, McGlinchey JB, et al. Assessing clinical significance: Does it matter which method we use? Journal of Consulting & Clinical Psychology. 2005;73:982–989.

Eisen SV, Normand SLT, Belanger AJ, et al. The revised Behavior and Symptom Identification Scale (BASIS-24©): Reliability and validity. Medical Care. 2004;42:1230–1241.

Guyatt GH, Norman GR, Juniper EF, et al. A critical look at transition ratings. Journal of Clinical Epidemiology. 2002;55:900–908.

Spitzer RL, Gibbon M, Endicott J. Global Assessment Scale (GAS), Global Assessment of Functioning (GAF) Scale, Social and Occupational Functioning Assessment Scale (SOFAS). In: Handbook of Psychiatric Measures. Washington DC: American Psychiatric Association; 2000:96–100.

Kazdin AE. Assessing the clinical or applied importance of behavior change through social validation. Behavior Modification. 1977;1:427–452.

Streiner DL, Norman GR.Health Measurement Scales. A Practical Guide to Their Development and Use (3rd ed.). New York: Oxford University Press 2003

Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimally important difference. Controlled Clinical Trials. 1991;10:407–415.

Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. Journal of Manipulative Physiological Therapeutics. 2004;27:26–35.

Ferguson RJ, Robinson AB, Splaine M. Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Quality of Life Research. 2002;11:509–516.

Clancy C, Eisenberg J. Outcomes research care: measuring the end results of health care. Science. 1998;282:245–246.

Cohen J.Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.

Testa M. Interpreting quality of life clinical trial data for use in the clinical practice of antihypertensive therapy. Journal of Hypertension Supplement. 1987;5:S9–S13.

Kazis Le, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Medical Care. 1989;27(Suppl 3):S178–S189.

Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life. The remarkable universality of half a standard deviation. Medical Care. 2003;5:582–592.

Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology. 1991;59:12–19.

Jacobson NS, Follette WC, Revenstorf. Psychotherapy outcome research. Methods for reporting variability and evaluating clinical significance. Behavior Therapy. 1984;15:336–352.

Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: description, application and alternatives. Journal of Consulting and Clinical Psychology. 1999;67:300–307.

Speer D. Methodological developments. Clinically significant change: Jacobson and Truax (1991) revisited. Journal of Consulting and Clinical Psychology. 1992;69(3):402–408.

Hageman WJM, Arrindell WA. A further refinement of the reliable change (RC) index by improving the pre–post difference score: introducing RCID. Behaviour Research and Therapy. 1993;31:693–700.

Anastasi A, Urbina S.Psychological Testing (7th ed.). Upper Saddle River, NJ: Prentice-Hall; 1997.

Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. Journal of Clinical Epidemiology. 1999;52:861–873.

Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Medical Care. 1999;37:469–478.

Eisen SV, Dill DL, Grob MC. Reliability and validity of a brief patient-report instrument for psychiatric outcome evaluation. Hospital & Community Psychiatry. 1994;45:242–247.

American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV). Washington D.C.: American Psychiatric Association; 1994.

Burlingame GM, Dunn TW, Chen S, et al. Selection of outcome assessment instruments for inpatients with severe and persistent mental illness. Psychiatric Services. 2005;56:444–451.

Eisen SV, Gerena M, Rangathan G, et al. Reliability and validity of the BASIS-24© Mental Health Survey for Whites, African-Americans and Latinos. Journal of Behavioral Health Services & Research. 2006;33:304–323.

Jerrell JM. Behavior and Symptom Identification Scale 32. Sensitivity to change over time. Journal of Behavioral Health Services & Research. 2005;32:341–346.

Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement. 1960;20:37–46.

Lambert MJ, Lambert JM. Use of psychological tests for assessing treatment outcome. In: Maruish ME, ed. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment (2nd ed.). Mahwah, NJ: Lawrence Erlbaum; 1999:115–152.

Jacobson NS, Roberts LJ, Berns SB, et al. Methods for defining and determining the clinical significance of treatment effects. Journal of Consulting and Clinical Psychology. 1999;67:300–307.

Ogles BM, Lambert MJ, Sawyer JD. Clinical significance of the National Institute of Mental Health treatment of depression collaborative research program data. Journal of Consulting and Clinical Psychology. 1995;63:321–326.

Guyatt H, Osoba D, Wu A, et al. Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings. 2002;77(4):373–383.

Jones SH, Thornicroft G, Coffey M, et al. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry. 1995;166:654–650.

Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). British Journal of Clinical Psychology. 2002;41:417–422.

Greenberg GA, Rosenheck RA. Using the GAS as a national mental health outcome measure in the Department of Veterans Affairs. Psychiatric Services. 2005;56:420–426.

Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. British Journal of Psychiatry. 2000;177:42–46.

Srebnick D, Hendryx M, Stevenson J, et al. Development of outcome indicators for monitoring the quality of public mental health care. Psychiatric Services. 1997;48:903–909.

Norman GR, Sridhar FG, Guyatt GH. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Medical Care. 2001;39:1039–1047.

Nunnally JC.Psychometric Theory. New York: McGraw-Hill; 1994.

Gilbody SM, House AO, Sheldon T. Routine administration of health related quality of life (HRQoL) and needs assessment instruments to improve psychological outcome—a systematic review. Psychological Medicine. 2002;32:1345–1356.

Garland AF, Kruse M, Aarons GA. Clinicians and outcome measurement: What’s the use? Journal of Behavioral Health Services & Research. 2003;30:393–405.